Rh1 high activity binding peptides inhibit high percentages of Plasmodium falciparum FVO strain invasion
Identifying the minimal functional regions of the proteins which the malaria parasite uses when invading its host cells constitutes the first and most important approach in an effective design for a chemically synthesised, multi-antigen, multi-stage, subunit-based vaccine. This work has been aimed a...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2013
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/23460
- Acceso en línea:
- https://doi.org/10.1016/j.vaccine.2013.01.052
https://repository.urosario.edu.co/handle/10336/23460
- Palabra clave:
- Amino acid
Membrane receptor
Protein
Rh1 protein
Unclassified drug
Alpha helix
Article
Cell invasion
Controlled study
Erythrocyte
Gene expression
In vitro study
Nonhuman
Plasmodium falciparum
Priority journal
Protein binding
Protein polymorphism
Reticulocyte
Schizont
Amino acid sequence
Erythrocytes
Host-pathogen interactions
Humans
Malaria
Malaria vaccines
Molecular sequence data
Peptides
Plasmodium falciparum
Protein structure, secondary
Protein structure, tertiary
Protozoan proteins
Schizonts
Malaria
Plasmodium falciparum
Reticulocyte binding-like
Synthetic peptide
subunit
Vaccines
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_26b3e0fccd7f60401075bf105c2573e3 |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/23460 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Rh1 high activity binding peptides inhibit high percentages of Plasmodium falciparum FVO strain invasion |
title |
Rh1 high activity binding peptides inhibit high percentages of Plasmodium falciparum FVO strain invasion |
spellingShingle |
Rh1 high activity binding peptides inhibit high percentages of Plasmodium falciparum FVO strain invasion Amino acid Membrane receptor Protein Rh1 protein Unclassified drug Alpha helix Article Cell invasion Controlled study Erythrocyte Gene expression In vitro study Nonhuman Plasmodium falciparum Priority journal Protein binding Protein polymorphism Reticulocyte Schizont Amino acid sequence Erythrocytes Host-pathogen interactions Humans Malaria Malaria vaccines Molecular sequence data Peptides Plasmodium falciparum Protein structure, secondary Protein structure, tertiary Protozoan proteins Schizonts Malaria Plasmodium falciparum Reticulocyte binding-like Synthetic peptide subunit Vaccines |
title_short |
Rh1 high activity binding peptides inhibit high percentages of Plasmodium falciparum FVO strain invasion |
title_full |
Rh1 high activity binding peptides inhibit high percentages of Plasmodium falciparum FVO strain invasion |
title_fullStr |
Rh1 high activity binding peptides inhibit high percentages of Plasmodium falciparum FVO strain invasion |
title_full_unstemmed |
Rh1 high activity binding peptides inhibit high percentages of Plasmodium falciparum FVO strain invasion |
title_sort |
Rh1 high activity binding peptides inhibit high percentages of Plasmodium falciparum FVO strain invasion |
dc.subject.keyword.spa.fl_str_mv |
Amino acid Membrane receptor Protein Rh1 protein Unclassified drug Alpha helix Article Cell invasion Controlled study Erythrocyte Gene expression In vitro study Nonhuman Plasmodium falciparum Priority journal Protein binding Protein polymorphism Reticulocyte Schizont Amino acid sequence Erythrocytes Host-pathogen interactions Humans Malaria Malaria vaccines Molecular sequence data Peptides Plasmodium falciparum Protein structure, secondary Protein structure, tertiary Protozoan proteins Schizonts Malaria Plasmodium falciparum Reticulocyte binding-like Synthetic peptide |
topic |
Amino acid Membrane receptor Protein Rh1 protein Unclassified drug Alpha helix Article Cell invasion Controlled study Erythrocyte Gene expression In vitro study Nonhuman Plasmodium falciparum Priority journal Protein binding Protein polymorphism Reticulocyte Schizont Amino acid sequence Erythrocytes Host-pathogen interactions Humans Malaria Malaria vaccines Molecular sequence data Peptides Plasmodium falciparum Protein structure, secondary Protein structure, tertiary Protozoan proteins Schizonts Malaria Plasmodium falciparum Reticulocyte binding-like Synthetic peptide subunit Vaccines |
dc.subject.keyword.eng.fl_str_mv |
subunit Vaccines |
description |
Identifying the minimal functional regions of the proteins which the malaria parasite uses when invading its host cells constitutes the first and most important approach in an effective design for a chemically synthesised, multi-antigen, multi-stage, subunit-based vaccine. This work has been aimed at identifying the PfRh1 protein binding regions (residues 1-2580) belonging to the reticulocyte binding-like (RBL or P. falciparum Rh [PfRh]) family implicated in the parasite's alternative target cell invasion routes. Eighteen peptide regions (called high activity binding peptides - HABPs) binding to red blood cells (RBC) were identified in peptides mapped in a highly robust, specific and sensitive receptor-ligand assay. These HABPs were saturable in the experimental conditions assayed here and most had an alpha helix structure. Polymorphism studies revealed that only six of the eighteen HABPs identified had changes at amino acid level amongst the seven P. falciparum strains evaluated. Most HABPs' specific binding became altered when RBC were treated with neuraminidase, chymotrypsin and trypsin, suggesting differing sensitivity for RBC membrane receptors. After ascertaining that the Rh1 gene was transcribed and expressed in late-stage schizonts of the FCB-2 strain, invasion inhibition assays were carried out. When most of these HABPs were assayed in P. falciparum in vitro culture they were able to inhibit high percentages of FVO strain invasion compared to low inhibition percentages observed with the FCB-2 strain. This data shows small Rh1 regions' participation during invasion and suggests that these units should be included in further immunological and structural studies. © 2013 Elsevier Ltd. |
publishDate |
2013 |
dc.date.created.spa.fl_str_mv |
2013 |
dc.date.accessioned.none.fl_str_mv |
2020-05-26T00:02:13Z |
dc.date.available.none.fl_str_mv |
2020-05-26T00:02:13Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1016/j.vaccine.2013.01.052 |
dc.identifier.issn.none.fl_str_mv |
0264410X 13588745 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/23460 |
url |
https://doi.org/10.1016/j.vaccine.2013.01.052 https://repository.urosario.edu.co/handle/10336/23460 |
identifier_str_mv |
0264410X 13588745 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
1837 |
dc.relation.citationIssue.none.fl_str_mv |
No. 14 |
dc.relation.citationStartPage.none.fl_str_mv |
1830 |
dc.relation.citationTitle.none.fl_str_mv |
Vaccine |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 31 |
dc.relation.ispartof.spa.fl_str_mv |
Vaccine, ISSN:0264410X, 13588745, Vol.31, No.14 (2013); pp. 1830-1837 |
dc.relation.uri.spa.fl_str_mv |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875262025&doi=10.1016%2fj.vaccine.2013.01.052&partnerID=40&md5=311561ae13a870b5a99facbc23290097 |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
institution |
Universidad del Rosario |
dc.source.instname.spa.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
bitstream.url.fl_str_mv |
https://repository.urosario.edu.co/bitstreams/351f8605-b6f1-42d5-9083-52a4e5610cd4/download https://repository.urosario.edu.co/bitstreams/a43c5767-7501-4da8-8f8f-e3a268cc7867/download https://repository.urosario.edu.co/bitstreams/358f4ecf-9b3a-49f7-bd30-a5fa23961a6c/download |
bitstream.checksum.fl_str_mv |
7854252c56fb9614bd0a60da7e348228 5aeba60b94632fc7faaa93f8b2c68cf2 c3f397f23244c69ca19051dc21bcd0f9 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167514303692800 |
spelling |
eca483d3-a229-42c8-8a6d-3b5e6f002e5b-191225589-1453006a5-2ec3-4faf-8e32-a9d7075d519d-19a090035-7467-44ed-a0ec-490f7325f9e8-179653065-110ecd4f9-843f-4ef2-bec0-7d39d3381a13-12020-05-26T00:02:13Z2020-05-26T00:02:13Z2013Identifying the minimal functional regions of the proteins which the malaria parasite uses when invading its host cells constitutes the first and most important approach in an effective design for a chemically synthesised, multi-antigen, multi-stage, subunit-based vaccine. This work has been aimed at identifying the PfRh1 protein binding regions (residues 1-2580) belonging to the reticulocyte binding-like (RBL or P. falciparum Rh [PfRh]) family implicated in the parasite's alternative target cell invasion routes. Eighteen peptide regions (called high activity binding peptides - HABPs) binding to red blood cells (RBC) were identified in peptides mapped in a highly robust, specific and sensitive receptor-ligand assay. These HABPs were saturable in the experimental conditions assayed here and most had an alpha helix structure. Polymorphism studies revealed that only six of the eighteen HABPs identified had changes at amino acid level amongst the seven P. falciparum strains evaluated. Most HABPs' specific binding became altered when RBC were treated with neuraminidase, chymotrypsin and trypsin, suggesting differing sensitivity for RBC membrane receptors. After ascertaining that the Rh1 gene was transcribed and expressed in late-stage schizonts of the FCB-2 strain, invasion inhibition assays were carried out. When most of these HABPs were assayed in P. falciparum in vitro culture they were able to inhibit high percentages of FVO strain invasion compared to low inhibition percentages observed with the FCB-2 strain. This data shows small Rh1 regions' participation during invasion and suggests that these units should be included in further immunological and structural studies. © 2013 Elsevier Ltd.application/pdfhttps://doi.org/10.1016/j.vaccine.2013.01.0520264410X13588745https://repository.urosario.edu.co/handle/10336/23460eng1837No. 141830VaccineVol. 31Vaccine, ISSN:0264410X, 13588745, Vol.31, No.14 (2013); pp. 1830-1837https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875262025&doi=10.1016%2fj.vaccine.2013.01.052&partnerID=40&md5=311561ae13a870b5a99facbc23290097Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURAmino acidMembrane receptorProteinRh1 proteinUnclassified drugAlpha helixArticleCell invasionControlled studyErythrocyteGene expressionIn vitro studyNonhumanPlasmodium falciparumPriority journalProtein bindingProtein polymorphismReticulocyteSchizontAmino acid sequenceErythrocytesHost-pathogen interactionsHumansMalariaMalaria vaccinesMolecular sequence dataPeptidesPlasmodium falciparumProtein structure, secondaryProtein structure, tertiaryProtozoan proteinsSchizontsMalariaPlasmodium falciparumReticulocyte binding-likeSynthetic peptidesubunitVaccinesRh1 high activity binding peptides inhibit high percentages of Plasmodium falciparum FVO strain invasionarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Arévalo-Pinzón, GabrielaCurtidor, HernandoMuñoz, MarinaSuarez, DianaPatarroyo, Manuel A.Patarroyo, Manuel E.ORIGINALRh1_high_activity_binding_peptides_inhib.pdfapplication/pdf792301https://repository.urosario.edu.co/bitstreams/351f8605-b6f1-42d5-9083-52a4e5610cd4/download7854252c56fb9614bd0a60da7e348228MD51TEXTRh1_high_activity_binding_peptides_inhib.pdf.txtRh1_high_activity_binding_peptides_inhib.pdf.txtExtracted texttext/plain48377https://repository.urosario.edu.co/bitstreams/a43c5767-7501-4da8-8f8f-e3a268cc7867/download5aeba60b94632fc7faaa93f8b2c68cf2MD52THUMBNAILRh1_high_activity_binding_peptides_inhib.pdf.jpgRh1_high_activity_binding_peptides_inhib.pdf.jpgGenerated Thumbnailimage/jpeg4673https://repository.urosario.edu.co/bitstreams/358f4ecf-9b3a-49f7-bd30-a5fa23961a6c/downloadc3f397f23244c69ca19051dc21bcd0f9MD5310336/23460oai:repository.urosario.edu.co:10336/234602022-05-02 07:37:14.606099https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |